• Something wrong with this record ?

Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death

L. Kasikova, I. Truxova, I. Cremer, C. Sautes-Fridman, O. Kepp, G. Kroemer, R. Spisek, J. Fucikova,

. 2020 ; 632 (-) : 15-25. [pub] 20190708

Language English Country United States

Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't

Immunogenic cell death (ICD), a functionally peculiar type of apoptosis, represents a unique way to deliver danger-associated molecular patterns (DAMPs) to the tumor microenvironment. Once emitted by dying cancer cells, DAMPs orchestrate antigen-specific immune responses by acting on both innate and adaptive components of the immune system. Accumulating preclinical and clinical evidence indicates that one of these DAMPs, calreticulin (CALR) represents a novel powerful prognostic biomarker, reflecting the activation of a clinically relevant anticancer immune response in different cancer malignancies. Therefore, the assessment of CALR emission can provide a therapeutic tool for the stratification of cancer patients and the identification of individuals that are intrinsically capable to respond to a particular treatment. Here we describe methods for the quantification of CALR exposure in the tumor microenvironment of cancer patients by flow cytometry and immunohistochemistry.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028650
003      
CZ-PrNML
005      
20210114154557.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/bs.mie.2019.05.025 $2 doi
035    __
$a (PubMed)32000894
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kasikova, Lenka $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; Sotio, Prague, Czech Republic.
245    10
$a Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death / $c L. Kasikova, I. Truxova, I. Cremer, C. Sautes-Fridman, O. Kepp, G. Kroemer, R. Spisek, J. Fucikova,
520    9_
$a Immunogenic cell death (ICD), a functionally peculiar type of apoptosis, represents a unique way to deliver danger-associated molecular patterns (DAMPs) to the tumor microenvironment. Once emitted by dying cancer cells, DAMPs orchestrate antigen-specific immune responses by acting on both innate and adaptive components of the immune system. Accumulating preclinical and clinical evidence indicates that one of these DAMPs, calreticulin (CALR) represents a novel powerful prognostic biomarker, reflecting the activation of a clinically relevant anticancer immune response in different cancer malignancies. Therefore, the assessment of CALR emission can provide a therapeutic tool for the stratification of cancer patients and the identification of individuals that are intrinsically capable to respond to a particular treatment. Here we describe methods for the quantification of CALR exposure in the tumor microenvironment of cancer patients by flow cytometry and immunohistochemistry.
650    _2
$a zvířata $7 D000818
650    _2
$a nádorové biomarkery $x analýza $x imunologie $7 D014408
650    _2
$a kalretikulin $x analýza $x imunologie $7 D037282
650    _2
$a průtoková cytometrie $x metody $7 D005434
650    _2
$a lidé $7 D006801
650    12
$a imunogenní buněčná smrt $7 D000079527
650    _2
$a imunohistochemie $x metody $7 D007150
650    _2
$a nádory $x imunologie $x patologie $7 D009369
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Truxova, Iva $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; Sotio, Prague, Czech Republic.
700    1_
$a Cremer, Isabelle $u Team Inflammation, Complement and Cancer, INSERM, Centre de Recherche des Cordeliers, Paris, France; Sorbonne Université, Paris, France.
700    1_
$a Sautes-Fridman, Catherine $u Team Inflammation, Complement and Cancer, INSERM, Centre de Recherche des Cordeliers, Paris, France; Sorbonne Université, Paris, France.
700    1_
$a Kepp, Oliver $u Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Descartes, Université Sorbonne Paris Cité, Université Paris Diderot, Sorbonne Université, INSERM, Paris, France; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
700    1_
$a Kroemer, Guido $u Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris Descartes, Université Sorbonne Paris Cité, Université Paris Diderot, Sorbonne Université, INSERM, Paris, France; Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France; Suzhou Institute for Systems Biology, Chinese Academy of Sciences, Suzhou, China; Department of Women's and Children's Health, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Spisek, Radek $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; Sotio, Prague, Czech Republic.
700    1_
$a Fucikova, Jitka $u Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic; Sotio, Prague, Czech Republic. Electronic address: fucikova@sotio.com.
773    0_
$w MED00008502 $t Methods in enzymology $x 1557-7988 $g Roč. 632, č. - (2020), s. 15-25
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32000894 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154553 $b ABA008
999    __
$a ok $b bmc $g 1608985 $s 1119830
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 632 $c - $d 15-25 $e 20190708 $i 1557-7988 $m Methods in enzymology $n Methods Enzymol $x MED00008502
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...